UK, EU & international health agencies
This small and medium-sized enterprises (SME) action plan sets out how we will enable SMEs to play their full part in the delivery of UKHSA’s mission and priorities.
The government will offer flu vaccination to those experiencing homelessness, beginning in autumn.
How to apply for a regulatory advice meeting on medical devices and in vitro diagnostic devices.
The HSRA is UKHSA’s assessment characterising a selection of the most significant health security risks facing the UK over the next 5 years.
UKHSA publishes its first Health Security Risk Assessment (HSRA), which characterises the most significant health security risks facing the UK over the next 5 years.
Government invests in artificial intelligence (AI) technologies to modernise the NHS and reduce waiting times.
Information about incidents and outbreaks of Ebola and Marburg, both viral haemorrhagic fevers (VHF).
Latest information on cases including British nationals.
How we engage and involve patients and the public in our regulatory decision-making.
Proposed changes to the headline payment percentage and consultation procedure of the statutory scheme to control the cost of branded health service medicines.
The London sandbox is a secure environment designed to safely test AI-enabled devices in a real-world environment so patients can benefit more quickly.
This report explains the progress of a review about mental health conditions, ADHD and autism.
Interim report outlining progress on the independent review into the prevalence and support for mental health conditions, ADHD and autism.
A grant determination letter outlining funding conditions and eligibility requirements to claim funding for user-led organisations in adult social care.
The government is on track to meet its manifesto promise that every school and college will have access to mental health support teams by the end of 2029
A toolkit to support local and regional stakeholders to understand and act on immunisation inequities in the populations they serve.
For healthcare professionals to email malaria prophylaxis queries to the Malaria Reference Laboratory (Malaria RL).
Thousands of men with prostate cancer are to be offered high-powered ‘precision’ radiotherapy on the NHS to target the disease more effectively, helping reduce side-effects and spare them 15 courses of treatment. NHS England has today announced that, for the first time, eligible men with early prostate cancer will be offered pioneering therapy known as […]
New AI sandbox will help make medicines safer, speed up development, and reduce reliance on animal testing.
As with all medicines, the MHRA will keep the safety and effectiveness of Nipolcalimab under close review.
The MHRA hosted a live Ask Me Anything on how artificial intelligence (AI) is being regulated in healthcare.
Key insights of simulation workshops from the AI Airlock testing programme. You should note that these documents are not formal guidance.
The MHRA’s AI Airlock second phase ran between April 2025 and May 2026. This report does not constitute formal MHRA guidance.
How the actual number of deaths in England compare with expected numbers for each week.